Replimune Group, Inc.
USD11.00
+0.49 (+4.66%)
CEO
Sushil Patel
IPO Date
2018-07-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$10.76
Prev. Close
$10.51
Day Low
$10.38
Day High
$11.18
52W Low
$1.50
52W High
$12.50
Market Cap
$0.92B
Volume
4.07M
| 14,023 |
| $5.08 |
| 20 May 2026 | Schwendenman Andrew | Chief Accounting Officer | S-Sale | Disposed | 7,894 | $5.08 |
| 20 May 2026 | Sarchi Christopher | Chief Commercial Officer | S-Sale | Disposed | 8,626 | $5.08 |
| 20 May 2026 | Astley-Sparke Philip | director | S-Sale | Disposed | 17,657 | $5.08 |
| 20 May 2026 | Patel Sushil | director, officer: Chief Executive Officer | S-Sale | Disposed | 37,324 | $5.08 |
| 20 May 2026 | Hill Emily Luisa | Chief Financial Officer | S-Sale | Disposed | 7,812 | $5.08 |
| 7 Apr 2026 | BAKER BROS. ADVISORS LP | director, 10 percent owner: | A-Award | Acquired | 44,500 | $7.61 |
| 7 Apr 2026 | Sarchi Christopher | Chief Commercial Officer | A-Award | Acquired | 50,000 | $0.00 |
| 7 Apr 2026 | Sarchi Christopher | Chief Commercial Officer | A-Award | Acquired | 75,000 | $7.61 |